Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
| No holders yet. | ||||||||||
Peter Thiel-backed psychedelics firm hits $2-billion valuation Atai Life Sciences gearing up for potential U.S. IPO as soon as the second quarter, sources say.